All News

As patients, we need to remember that we may not wear the white coat, but we definitely wear the pants in the doctor-patient relationship

The FDA has approved Herzuma (trastuzumab-pkrb) (Herzuma) as a biosimilar to Herceptin (trastuzumab, Genentech). Trastuzumab-pkrb is a HER2/neu receptor antagonist indicated for the treatment of HER2-overexpressing breast cancer.

The Food and Drug Administration has approved Nplate for pediatric patients 1 year of age and older with immune thrombocytopenia who have had an insufficient response to medications, such as corticosteroids,or surgery to remove the spleen.

Instead of fighting the roadblocks that cancer can prevent, what would happen if we embraced them?

Cancer has led me to men and women who grabbed onto life but died anyway.

Frontline use of Imbruvica (ibrutinib) in combination with Gazyva (obinutuzumab) significantly reduced the risk for disease progression or death among patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), especially in those with high-risk disease.

I try so hard to be positive, but in the back of my mind, I am constantly waiting for the other shoe to drop, for my blood counts to worsen, for the results of the next bone marrow biopsy to be haywire, for the chemo with its side effects to be administered, intensified or changed.

People with cancer who subscribe to a strong spiritual belief system report a better ability to cope.

Winter Storm Diego delivered two things... three days off from work and a set of clean scans!

The combination of Darzalex (daratumumab), Revlimid (lenalidomide) and dexamethasone significantly reduced the risk for disease progression in patients with newly diagnosed multiple myeloma.

There are methods to cope with ongoing cancer research and worry.

Here’s another throwback to one of our 2008 issues, where genetic testing was just gaining steam in the cancer space.

Measuring circulating tumor DNA in the blood of patients with advanced mantle cell lymphoma may be a viable way to predict how well they will respond to specific therapies.

When I was diagnosed with a hereditary cancer syndrome, I had feelings of death anxiety.

The high cost of treatment for cancer places a heavy burden on patients and their families, often leading to stress-related illnesses. Is there a solution?

More than 40 percent of patients with a myeloproliferative neoplasm reported that they were unsatisfied with their current pain management strategy.

Funding cutting-edge research for all forms of cancer Funds Matched by Bristol-Myers Squibb for a Total of $1.3 Million to be used for Breakthrough Cancer Research

Treatment with Velcade (bortezomib) following induction chemotherapy and stem cell transplantation seemed safe and effective for untreated patients with mantle cell lymphoma, encouraging further evaluation for more active, less toxic targeted agents.

An essay on seeing cancer from a childhood treehouse.

Four years' worth of high-stakes scans have made me an expert in four excellent ways to ease intense anxiety.

Take a look at content from CURE Magazine from 10 years ago to see how the myeloma space – and our magazine in general – has changed!

In the general population, African Americans tend to have poorer myeloma outcomes; however, that may not be the case for veterans.

Our habits can support our ability to find joy.

Tis the season to be jolly! Here are some ways to support a loved one with cancer during this festive wintertime.

In patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL), high doses of curcumin and vitamin D could help stabilize the disease, according to new research presented at the American Society of Hematology’s (ASH) Annual Meeting in San Diego.

Having a health care directive in your medical records is one favor you can do your family, and in some of the most unexpected and unavoidable times, they will be grateful you have it.

The Food and Drug Administration has approved Tecentriq (atezolizumab) for use in combination with Avastin (bevacizumab), carboplatin, paclitaxel, the treatment combination known as ABCP, for the first-line treatment of patients with metastatic nonsquamous non-small cell lung cancer (NSCLC).

A recent study looked at a new combination to determine what would happen if untreated patients eligible for transplant were given alternating cycles of Rituxan plus bendamustine and Rituxan plus cytarabine as induction therapy. The study pooled findings from two clinical trials and real-world experience.

Once you or someone you love has been diagnosed with something big, the times between scans become sacred in-between times where you do your best to live in light of the ever-changing circumstances of your body. Sometimes that can be a time full of fear, but others it is a time full of hope.

I spend so much time trying to go back to the past or predict the future that I tend to forget how to live in today's moments.